DAIC

JANUARY 3, 2024

Since its inception, HeartFlow has been committed to building a new standard of care for people at risk of heart disease. For over a decade, HeartFlow’s deep partnerships with more than 1,000 hospitals globally, including 80% of the top 50 heart hospitals in the U.S., Arbab-Zadeh, Heart Int 2012. Neth Heart J 2018.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

Stroke Journal

JANUARY 30, 2025

This study aimed to determine the current prevalence of CAS and examine the associated gender differences in adults.Methods:From September 2021 to June 2022, we established a prospective cohort to study CAS and cardiovascular disease across 25 project sites in Henan, China, utilizing a multistage whole-population sampling method.

Atherosclerosis 40

Atherosclerosis Plaque Stenosis Cardiovascular Disease 40

Physiologically Speaking

APRIL 10, 2024

people from the general population), coronary artery calcium scores (CACS) are higher, indicating more calcification and the presence of atherosclerotic plaques. Calcified plaques are known to be more stable and less prone to rupture and lead to a heart attack. When comparing athletes to control groups (i.e., hours per week).

Atherosclerosis 52

Atherosclerosis Plaque Exercise Cardiovascular Disease 52

DAIC

FEBRUARY 8, 2024

In 2021, there were 7.44 million deaths attributable to stroke worldwide and about half of those were ischemic stroke, according to the most recent data in the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association. In 2021, there were 7.44 In the U.S.,

Research 105

Research Strokes Stroke Heart Attack 105

DAIC

MAY 16, 2024

PAD is a serious, progressive cardiovascular disease primarily caused by a buildup of fatty plaque in the blood vessels, or atherosclerosis. This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

EMS 12-Lead

JUNE 1, 2022

plaque disruption), the T waves still manifest markings of a previous state of suboptimal coronary flow that resolved: Type II supply-demand mismatch in the setting of extreme bradycardia. LBBB is typically the result of preexisting hypertrophy, ischemic heart disease, or cardiomyopathy. European Heart Journal, 28 , 2449-2455.

Heart Failure 52

Heart Failure Myocardial Infarction Bradycardia Chest Pain 52

Dr. Smith's ECG Blog

FEBRUARY 6, 2025

There were no plaques or stenoses. See here: Narrow Complex Tachycardia at a Rate of 220 Below is a Practical Approach to Flecainide Dosing: Exclude contraindications such as structural heart disease; symptomatic bradycardia; 2nd-degree or high-degree AV block; QRS >120 msec.; Underlying Heart Disease?

Tachycardia 72

Tachycardia Arrhythmia Atrial Flutter Ablation 72